My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 337

    1.

    Effects of n-3 polyunsaturated fatty acids on glucose homeostasis and blood pressure in essential hypertension. A randomized, controlled trial.

    Toft I, Bønaa KH, Ingebretsen OC, Nordøy A, Jenssen T.

    Ann Intern Med. 1995 Dec 15;123(12):911-8.PMID: 7486485 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension.

    Woodman RJ, Mori TA, Burke V, Puddey IB, Watts GF, Beilin LJ.

    Am J Clin Nutr. 2002 Nov;76(5):1007-15.PMID: 12399272 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    A controlled study on the effects of n-3 fatty acids on lipid and glucose metabolism in non-insulin-dependent diabetic patients.

    Annuzzi G, Rivellese A, Capaldo B, Di Marino L, Iovine C, Marotta G, Riccardi G.

    Atherosclerosis. 1991 Mar;87(1):65-73.PMID: 1872925 [PubMed - indexed for MEDLINE]Related articles

    4.

    Long-term effects of fish oil on insulin resistance and plasma lipoproteins in NIDDM patients with hypertriglyceridemia.

    Rivellese AA, Maffettone A, Iovine C, Di Marino L, Annuzzi G, Mancini M, Riccardi G.

    Diabetes Care. 1996 Nov;19(11):1207-13.PMID: 8908381 [PubMed - indexed for MEDLINE]Related articles

    5.

    Effect of eicosapentaenoic and docosahexaenoic acids on blood pressure in hypertension. A population-based intervention trial from the Tromsø study.

    Bønaa KH, Bjerve KS, Straume B, Gram IT, Thelle D.

    N Engl J Med. 1990 Mar 22;322(12):795-801.PMID: 2137901 [PubMed - indexed for MEDLINE]Related articles

    6.

    Effects of n-3 fatty acids in subjects with type 2 diabetes: reduction of insulin sensitivity and time-dependent alteration from carbohydrate to fat oxidation.

    Mostad IL, Bjerve KS, Bjorgaas MR, Lydersen S, Grill V.

    Am J Clin Nutr. 2006 Sep;84(3):540-50. Erratum in: Am J Clin Nutr. 2007 Jun;85(6):1668. PMID: 16960167 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Improvement of insulin sensitivity by metformin treatment does not lower blood pressure of nonobese insulin-resistant hypertensive patients with normal glucose tolerance.

    Dorella M, Giusto M, Da Tos V, Campagnolo M, Palatini P, Rossi G, Ceolotto G, Felice M, Semplicini A, Del Prato S.

    J Clin Endocrinol Metab. 1996 Apr;81(4):1568-74.PMID: 8636369 [PubMed - indexed for MEDLINE]Related articles

    8.

    Metabolic and cardiovascular effects of carvedilol and atenolol in non-insulin-dependent diabetes mellitus and hypertension. A randomized, controlled trial.

    Giugliano D, Acampora R, Marfella R, De Rosa N, Ziccardi P, Ragone R, De Angelis L, D'Onofrio F.

    Ann Intern Med. 1997 Jun 15;126(12):955-9.PMID: 9182472 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Moderate intake of n-3 fatty acids for 2 months has no detrimental effect on glucose metabolism and could ameliorate the lipid profile in type 2 diabetic men. Results of a controlled study.

    Luo J, Rizkalla SW, Vidal H, Oppert JM, Colas C, Boussairi A, Guerre-Millo M, Chapuis AS, Chevalier A, Durand G, Slama G.

    Diabetes Care. 1998 May;21(5):717-24.PMID: 9589230 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Blood pressure lowering in elderly subjects: a double-blind crossover study of omega-3 and omega-6 fatty acids.

    Margolin G, Huster G, Glueck CJ, Speirs J, Vandegrift J, Illig E, Wu J, Streicher P, Tracy T.

    Am J Clin Nutr. 1991 Feb;53(2):562-72.PMID: 1989427 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men.

    Mori TA, Burke V, Puddey IB, Watts GF, O'Neal DN, Best JD, Beilin LJ.

    Am J Clin Nutr. 2000 May;71(5):1085-94.PMID: 10799369 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Improvement of serum lipids and blood pressure during intervention with n-3 fatty acids was not associated with changes in insulin levels in subjects with combined hyperlipidaemia.

    Grundt H, Nilsen DW, Hetland O, Aarsland T, Baksaas I, Grande T, Woie L.

    J Intern Med. 1995 Mar;237(3):249-59.PMID: 7891046 [PubMed - indexed for MEDLINE]Related articles

    13.

    The effects of low doses of n-3 fatty acid supplementation on blood pressure in hypertensive subjects. A randomized controlled trial.

    Radack K, Deck C, Huster G.

    Arch Intern Med. 1991 Jun;151(6):1173-80.PMID: 1828336 [PubMed - indexed for MEDLINE]Related articles

    14.

    Short report: the effect of fish oil on blood pressure and high-density lipoprotein-cholesterol levels in phase I of the Trials of Hypertension Prevention.

    Sacks FM, Hebert P, Appel LJ, Borhani NO, Applegate WB, Cohen JD, Cutler JA, Kirchner KA, Kuller LH, Roth KJ, et al.

    J Hypertens. 1994 Feb;12(2):209-13.PMID: 8021472 [PubMed - indexed for MEDLINE]Related articles

    15.

    Eicosapentaenoic acid and docosahexaenoic acid from fish oils: differential associations with lipid responses.

    Leigh-Firbank EC, Minihane AM, Leake DS, Wright JW, Murphy MC, Griffin BA, Williams CM.

    Br J Nutr. 2002 May;87(5):435-45.PMID: 12010583 [PubMed - indexed for MEDLINE]Related articles

    16.

    Fibrinolytic function after dietary supplementation with omega3 polyunsaturated fatty acids.

    Toft I, Bønaa KH, Ingebretsen OC, Nordøy A, Jenssen T.

    Arterioscler Thromb Vasc Biol. 1997 May;17(5):814-9.PMID: 9157942 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Fish oil, insulin sensitivity, insulin secretion and glucose tolerance in healthy people: is there any effect of fish oil supplementation in relation to the type of background diet and habitual dietary intake of n-6 and n-3 fatty acids?

    Giacco R, Cuomo V, Vessby B, Uusitupa M, Hermansen K, Meyer BJ, Riccardi G, Rivellese AA; KANWU Study Group.

    Nutr Metab Cardiovasc Dis. 2007 Oct;17(8):572-80. Epub 2006 Nov 28.PMID: 17127043 [PubMed - indexed for MEDLINE]Related articles

    18.

    The effects of metformin on glycemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control.

    Robinson AC, Burke J, Robinson S, Johnston DG, Elkeles RS.

    Diabetes Care. 1998 May;21(5):701-5.PMID: 9589227 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    A comparison of fish oil or corn oil supplements in hyperlipidemic subjects with NIDDM.

    Morgan WA, Raskin P, Rosenstock J.

    Diabetes Care. 1995 Jan;18(1):83-6.PMID: 7698053 [PubMed - indexed for MEDLINE]Related articles

    20.

    Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: The Systolic Hypertension in the Elderly Program. SHEP Cooperative Research Group.

    Savage PJ, Pressel SL, Curb JD, Schron EB, Applegate WB, Black HR, Cohen J, Davis BR, Frost P, Smith W, Gonzalez N, Guthrie GP, Oberman A, Rutan G, Probstfield JL, Stamler J.

    Arch Intern Med. 1998 Apr 13;158(7):741-51.PMID: 9554680 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity